Thus, the cooperation between eIF4A/4E-dependent mRNA translation and MVP has been identified as a link in which representative pancreatic driver mutations empower an ARF6-based pathway, activated by external ligands, to promote tumor cell motility, PD-L1 dynamics, and immune evasion. The gene discussed is ARF6; the disease is neoplasm.